Prosecution Insights
Last updated: April 19, 2026
Application No. 18/194,442

MEDICAL CONNECTORS

Non-Final OA §102
Filed
Mar 31, 2023
Examiner
BOUCHELLE, LAURA A
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
ICU Medical, Inc.
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
3y 4m
To Grant
90%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allow Rate
952 granted / 1188 resolved
+10.1% vs TC avg
Moderate +10% lift
Without
With
+10.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
47 currently pending
Career history
1235
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
43.9%
+3.9% vs TC avg
§102
28.3%
-11.7% vs TC avg
§112
15.6%
-24.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1188 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim 1 is objected to because of the following informalities: claim 1 recites, in relevant part, “a distal opening at a distal end of the projection; a proximal end with a proximal opening; a fluid pathway that extends between the distal opening and the proximal opening, wherein the fluid pathway extends inside the projection’ a valve disposed inside the projection and having a closed configuration that closes the distal opening of the fluid pathway and an open configuration that opens the distal opening of the fluid pathway” [emphasis added]. The claim defines the distal opening at a distal end of the projection, and a fluid pathway extending between the distal opening and the proximal opening. While it appears that the claim is referring to a single distal opening, the claim language “the distal opening of the fluid pathway” is not consistent with the prior limitation which describes the distal opening at a distal end “of the projection”. Appropriate correction is required. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 19, 24, 25 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Fangrow (US 10,697,570). Regarding claim 19, Fangrow discloses medical connector (figs. 50, 50A) comprising: a housing having: an outer wall; a first opening; a second opening; and a fluid pathway between the first opening and the second opening; and a hollow projection that defines an interior cavity that forms a portion of the fluid pathway, the projection disposed inward of the outer wall to form a cavity between the projection and the outer wall; a valve 1117 disposed inside the projection, the valve having a closed position with an end of the valve substantially flush with an end of the projection to close the fluid pathway (fig. 50) and an open position with the end of the valve recessed inside the projection to open the fluid pathway (fig. 52); and a cover disposed in the cavity between the projection and the outer wall (fig. 52), wherein the cover has a first configuration with the cover disposed substantially flush with the end of the valve and substantially flush with the end of the projection (fig. 50A). See Figs. 50, 50A, 52 annotated below. PNG media_image1.png 863 828 media_image1.png Greyscale PNG media_image2.png 581 856 media_image2.png Greyscale PNG media_image3.png 516 882 media_image3.png Greyscale Regarding claim 24, Fangrow discloses that the cover is configured to be pushed along an exterior of the projection when a second medical connection is coupled to the medical connector (see fig. 52 above). Regarding claim 25, Fangrow discloses that the cover is configured to form a seal with a housing 1468 of the second medical connector (Fig. 50A). Allowable Subject Matter Claims 1-18, 30-38 are allowed. Claims 20-23, 26-30 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: the breakaway medical connector as claimed could not be found and was not suggested by the prior art of record, particularly the first engagement features, a breakaway member comprising second engagement features that engage the first engagement features, and a coupling interface configured to couple to a second medical connector and to position the second medical connector to open the valve when the second medical connector is coupled to the breakaway member when the second engagement features are engaged with the first engagement features, and wherein the first engagement features and the second engagement features are configure to disengage if a force above a threshold pulls the breakaway member in a distal direction, to thereby provide a breakaway disconnection, in combination with the features of the invention, substantially as claimed. Similarly, the prior art fails to teach a method of using a breakaway connector comprising the steps of detaching the breakaway member and the second medical connector from the main body of the first medical connector by pulling the second connector away from the first connector, wherein the breakaway member remains coupled to the second medical connector after the detachment, and reattaching the breakaway member to the main body of the first medical connector without needing a tool, in combination with the features of the invention, substantially as claimed. Breakaway connectors are known in the art as taught by Hallisey et al (US 10,569,073) for example, however, the prior art fails to teach the valve, the first and second engagement features and the coupling interface as claimed. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LAURA A BOUCHELLE whose telephone number is (571)272-2125. The examiner can normally be reached Mon-Fri 8:00-5:00 CST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bhisma Mehta can be reached at 571-272-3383. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. LAURA A. BOUCHELLE Primary Examiner Art Unit 3783 /LAURA A BOUCHELLE/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Mar 31, 2023
Application Filed
Jun 19, 2023
Response after Non-Final Action
Jan 06, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594377
SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATION
2y 5m to grant Granted Apr 07, 2026
Patent 12589205
WET INJECTION DETECTION AND PREVENTION SYSTEM AND METHOD
2y 5m to grant Granted Mar 31, 2026
Patent 12589025
INTRAOCULAR DEVICES, SYSTEMS, AND METHODS
2y 5m to grant Granted Mar 31, 2026
Patent 12589026
MICRO DOSING DEVICE AND METHOD OF ASSEMBLY OF THE MICRO DOSING DEVICE
2y 5m to grant Granted Mar 31, 2026
Patent 12589221
MECHANICALLY-DECOUPLED ACTUATION FOR ROBOTIC CATHETER SYSTEM
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
90%
With Interview (+10.3%)
3y 4m
Median Time to Grant
Low
PTA Risk
Based on 1188 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month